rs144613953

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004204.5(PIGQ):​c.1546C>A​(p.Arg516Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00235 in 1,607,022 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R516H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., cov: 34)
Exomes 𝑓: 0.0025 ( 12 hom. )

Consequence

PIGQ
NM_004204.5 missense

Scores

3
14

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.17

Publications

4 publications found
Variant links:
Genes affected
PIGQ (HGNC:14135): (phosphatidylinositol glycan anchor biosynthesis class Q) This gene is involved in the first step in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This gene encodes a N-acetylglucosaminyl transferase component that is part of the complex that catalyzes transfer of N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to phosphatidylinositol (PI). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2012]
PIGQ Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 77
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.018725783).
BP6
Variant 16-582262-C-A is Benign according to our data. Variant chr16-582262-C-A is described in ClinVar as Likely_benign. ClinVar VariationId is 456035.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00131 (200/152362) while in subpopulation NFE AF = 0.00229 (156/68026). AF 95% confidence interval is 0.002. There are 0 homozygotes in GnomAd4. There are 82 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 12 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIGQNM_004204.5 linkc.1546C>A p.Arg516Ser missense_variant Exon 10 of 11 ENST00000321878.10 NP_004195.2 Q9BRB3-2B2RAU6
PIGQNM_148920.4 linkc.1532-621C>A intron_variant Intron 9 of 9 NP_683721.1 Q9BRB3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIGQENST00000321878.10 linkc.1546C>A p.Arg516Ser missense_variant Exon 10 of 11 1 NM_004204.5 ENSP00000326674.6 Q9BRB3-2

Frequencies

GnomAD3 genomes
AF:
0.00131
AC:
200
AN:
152244
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000289
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00157
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00229
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00159
AC:
379
AN:
239062
AF XY:
0.00164
show subpopulations
Gnomad AFR exome
AF:
0.000264
Gnomad AMR exome
AF:
0.00182
Gnomad ASJ exome
AF:
0.000205
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000253
Gnomad NFE exome
AF:
0.00239
Gnomad OTH exome
AF:
0.00188
GnomAD4 exome
AF:
0.00246
AC:
3572
AN:
1454660
Hom.:
12
Cov.:
31
AF XY:
0.00241
AC XY:
1745
AN XY:
723146
show subpopulations
African (AFR)
AF:
0.000420
AC:
14
AN:
33362
American (AMR)
AF:
0.00193
AC:
86
AN:
44470
Ashkenazi Jewish (ASJ)
AF:
0.0000769
AC:
2
AN:
26022
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39452
South Asian (SAS)
AF:
0.000984
AC:
84
AN:
85394
European-Finnish (FIN)
AF:
0.000390
AC:
20
AN:
51344
Middle Eastern (MID)
AF:
0.00122
AC:
7
AN:
5756
European-Non Finnish (NFE)
AF:
0.00293
AC:
3246
AN:
1108790
Other (OTH)
AF:
0.00188
AC:
113
AN:
60070
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
152
305
457
610
762
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00131
AC:
200
AN:
152362
Hom.:
0
Cov.:
34
AF XY:
0.00110
AC XY:
82
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.000289
AC:
12
AN:
41586
American (AMR)
AF:
0.00157
AC:
24
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00229
AC:
156
AN:
68026
Other (OTH)
AF:
0.00236
AC:
5
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
11
22
32
43
54
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00210
Hom.:
26
Bravo
AF:
0.00151
TwinsUK
AF:
0.00324
AC:
12
ALSPAC
AF:
0.00337
AC:
13
ESP6500AA
AF:
0.000228
AC:
1
ESP6500EA
AF:
0.00291
AC:
25
ExAC
AF:
0.00156
AC:
188
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
Apr 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PIGQ: BP4 -

Epilepsy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 77 Benign:1
Jun 07, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Uncertain
-0.020
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.034
.;.;T
Eigen
Benign
-0.32
Eigen_PC
Benign
-0.19
FATHMM_MKL
Benign
0.61
D
LIST_S2
Benign
0.82
.;T;T
M_CAP
Benign
0.030
D
MetaRNN
Benign
0.019
T;T;T
MetaSVM
Benign
-1.1
T
PhyloP100
1.2
PROVEAN
Benign
-1.6
N;N;N
REVEL
Benign
0.21
Sift
Benign
0.063
T;T;D
Sift4G
Uncertain
0.034
D;D;D
Polyphen
0.20
B;B;.
Vest4
0.70
MVP
0.33
ClinPred
0.015
T
GERP RS
2.8
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144613953; hg19: chr16-632262; API